FindTrial
Sign In

Risk Factors for Osteopenia in Gout Patients and the Association Between Uric Acid Levels and Site-Specific Bone Mineral Density

Risk Factors for Osteopenia in Gout Patients and the Association Between Uric Acid Levels and Site-Specific Bone Mineral Density

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500103399
Enrollment
Unknown
Registered
2025-05-28
Start date
2025-04-30
Completion date
Unknown
Last updated
2025-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gout

Interventions

osteoporosis group:NA
osteopenia group:NA
contronl group:NA

Sponsors

Affiliated Hospital of Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: All patients were diagnosed with primary gout based on the 1977 American College of Rheumatology (ACR) criteria, all participants were assessed for bone mineral density (BMD) and bone metabolism markers.

Exclusion criteria

Exclusion criteria: (1) experienced a gout flare within 2 weeks before enrollment; (2) had a history of malignancies, autoimmune diseases, thyroid disorders, or organ dysfunction/failure (defined as an estimated glomerular filtration rate [eGFR] 2.5 times the upper limit of normal [ULN]); (3) used urate-lowering drugs or other medications affecting serum urate levels within the past 3 months; (4) took medications influencing bone metabolism, such as bisphosphonates, systemic glucocorticoids, or hormonal therapies.

Design outcomes

Primary

MeasureTime frame
bone mineral density;Bone Turnover Markers;Serum biochemical data;Baseline data;—

Countries

China

Contacts

Public ContactLiu Tian

Affiliated Hospital of Qingdao University

liutian.1988.1014@163.com+86 186 6180 9197

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026